American depositary receipts of European stocks were trading 0.75% lower at 141.22 on the Bank of New York Mellon Europe ADR Index on Thursday.
In continental Europe, the gainers were led by biotech firms Zealand Pharma ( ZEAL ), and MorphoSys ( MOR ), which rose 3.3% and 3.2% respectively. They were followed by medical equipment maker Edap ( EDAP ), and biotech company argenx ( ARGX ), which were up 3.0% and 2.3%.
The decliners in continental Europe were led by insurance firm Aegon ( AEG ), and furniture maker Natuzzi (NTZ), which lost 3.9% and 3.7% respectively. Meanwhile, brewng company AB InBev (BUD), and telecommunications provider Telecom Italia (TI) were off 3.2% and 3.0%.
In the UK and Ireland, the gainers were led by pharmaceutical company Avadel (AVDL), which climbed 5.8, and biopharmaceutical firm Adaptimmune Therapeutics (ADAP), which rose 2.9%. They were followed by Royal Bank of Scotland (RBS), and communications group WPP (WPP), which rose 2.0% and 1.6%.
The decliners in the UK and Ireland were led by telecommunications provider BT Group (BT), and mining company Randgold Resources (GOLD), which dropped 9.0% and 6.6% respectively. They were followed by biopharmaceutical company Amarin (AMRN), and building materials supplier CRH (CRH), which shed 1.3% and 1.0%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.